MedDay is a French biotech company in the treatment of neuro-metabolic diseases. Founded in 2011 by Frédéric Sedel and Guillaume Brion, MedDay relies on the work of Dr Frédéric Sedel, a neuroscientist at La Pitié Salpêtrière Hospital (Paris), who has been carrying out pioneering research in neurology to identify rare hereditary metabolic diseases in adults for more than a decade. Dr Frédéric Sedel’s research has led to the identification of new treatments and diagnostic tools for diseases in a field where few treatments, if any, are available. The company is currently incubated at l’Institut du Cerveau et de la Moelle épinière in Paris (ICM).
Location: France, Ile-of-France, Paris
Employees: 51-200
Total raised: $49.21M
Founded date: 2011
Investors 2
| Date | Name | Website |
| - | Sofinnova ... | sofinnovap... |
| - | Andera Par... | anderapart... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 08.04.2016 | Series B | $38.76M | - |
| 09.04.2013 | - | $10.45M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 08.04.2016 | Daily funding roundup - April 8, 2016 | Getui bagged $180M; Twiggle secured $12.5M; KiteDesk completed $6M funding round RiskRecon landed se... | vator.tv/n... |
| 08.04.2016 | MedDay Raises €34M in Series B Funding | MedDay, a Paris, France-based biotechnology company focused on the treatment of nervous system disor... | finsmes.co... |
| 08.04.2016 | MedDay raises $38.5M to kick off U.S. clinical trials for mu... | “The SPI2 study is expected to confirm, in a large North American population, the results of our pri... | medcitynew... |
| 09.04.2013 | MedDay Raises €8M in Funding | MedDay, a Paris, France-based biotech company, raised €8m in funding. Backers included InnoBio, a bi... | finsmes.co... |
| - | MedDay raises $38.5M to kick off U.S. clinical trials for mu... | French biotech startup MedDay Pharmaceuticals just scored a $38.5 million Series B round, with aims ... | medcitynew... |